V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20054258 | 20088908 | 1.66 | 85 | null | 2019-08-28 | 2019-09-04 | Bortezomib + MELPHALAN | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101133641 |
| 20054283 | 20088909 | 1.59 | 75.2 | Palliative (P) | 2016-10-26 | 2016-11-09 | FOXTROT TRIAL | N | N | RITUXIMAB | 100040411 |
| 20054581 | 20088910 | 1.69 | 63.8 | 03 | 2018-10-10 | 2018-12-09 | Gemcitabine + Paclitaxel | null | N | CAPITAL TRIAL | 100582698 |
| 20055654 | 20088911 | 1.6 | 45.6 | Palliative (P) | 2019-03-19 | 2019-03-19 | CHOP R - 21 days | 02 | N | GEMCARBO | 101690878 |
| 20055720 | 20088912 | 1.66 | 56.3 | 03 | 2020-08-03 | 2020-08-05 | SCOPE 2 TRIAL | 2 | N | CAPECITABINE + STREPTOZOCIN | 100599059 |
| 20056098 | 20088913 | 1.77 | 66.4 | 03 | 2017-11-19 | 2017-11-22 | BCG Intravesical | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100274297 |
| 20057153 | 20088914 | 1.75 | 73.9 | 03 | null | 2018-10-05 | ACELARATE Trial | Y | Y | PLATO TRIAL | 100418039 |
| 20057235 | 20088915 | 1.55 | 80.95 | 03 | 2019-10-08 | 2019-10-08 | null | 02 | N | HYDROXYCARBAMIDE | 100996265 |
| 20057847 | 20088916 | 1.17 | 96 | null | 2016-02-15 | 2016-03-04 | Doxorubicin 75mg/m2 | 01 | N | IRINOTECAN | 101212682 |
| 20058058 | 20088917 | 1.6 | 57 | Palliative (P) | 2019-07-09 | 2019-07-26 | SCOPE 2 TRIAL | 02 | N | DABRAFENIB + TRAMETINIB | 100370115 |
| 20058775 | 20088919 | 1.78 | 68.5 | Palliative (P) | null | 2017-08-01 | Cisplatin + Docetaxel | 01 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 100807004 |
| 20058995 | 20088920 | 1.6 | 93.2 | Palliative (P) | 2020-01-22 | 2020-01-26 | EEF or EOF | 02 | N | CHLORAMBUCIL + PROCARBAZINE + VINBLASTINE | 100995173 |
| 20060314 | 20088923 | 1.68 | 77.2 | Palliative (P) | 2019-07-23 | 2019-08-04 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101012068 |
| 20060754 | 20088924 | 1.8 | 99 | Palliative (P) | 2017-10-03 | 2017-10-30 | Raltitrexed | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101781127 |
| 20062280 | 20088927 | 1.74 | 76.3 | Adjuvant (A) | 2017-10-31 | 2017-11-04 | Arsenic trioxide + Tretinoin | 02 | N | IBRUTINIB | 101037562 |
| 20062395 | 20088928 | 1.65 | 71 | Palliative (P) | 2018-10-11 | 2018-10-28 | Irinotecan | 01 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100680052 |
| 20062437 | 20088929 | 1.8 | 56.8 | Palliative (P) | 2017-05-09 | 2017-05-24 | CYCLOPHOSPHAMIDE + EPIRUBICIN | 2 | N | CAPECITABINE + STREPTOZOCIN | 101004426 |
| 20062528 | 20088930 | 1.8 | 86 | Curative (C) | 2017-05-16 | 2017-05-16 | CAP + RT | null | N | ESPAC TRIAL | 100767032 |
| 20062624 | 20088931 | 1.68 | 79 | Adjuvant (A) | 2019-06-21 | 2019-07-05 | DOXORUBICIN | 02 | N | NOT MATCHED | 100673263 |
| 20062756 | 20088932 | 1.53 | 89.3 | Palliative (P) | 2019-09-27 | 2019-10-09 | EOF | 02 | N | IVA | 100793430 |
| 20063027 | 20088933 | 1.7 | 94.9 | Palliative (P) | 2019-11-30 | 2019-11-30 | PLATO Trials | 02 | N | PLATO TRIAL | 101669201 |
| 20063333 | 20088934 | 1.66 | 33.2 | 03 | 2019-05-30 | 2019-06-01 | Rituximab (Maintenance) | 02 | Y | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100792190 |
| 20063588 | 20088935 | 1.74 | 71.9 | Palliative (P) | 2017-05-30 | 2017-06-09 | SCOPE 2 TRIAL | N | N | FOXTROT TRIAL | 101387347 |
| 20064113 | 20088936 | 1.8 | 105 | 03 | 2020-01-24 | 2020-01-25 | ECarboX | 02 | N | ESPAC TRIAL | 101308208 |
| 20064156 | 20088937 | 1.51 | 16 | Palliative (P) | 2019-02-11 | 2019-02-21 | null | 02 | N | BORTEZOMIB + CYCLOPHOSPHAMIDE | 100563720 |
| 20064678 | 20088938 | 1.65 | 59.85 | 03 | 2016-04-23 | 2016-04-24 | Cytarabine Low Dose | 01 | N | CARBOPLATIN + FLUOROURACIL + STREPTOZOCIN | 101019356 |
| 20065210 | 20088939 | 1.73 | 77.15 | Palliative (P) | null | 2019-04-04 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | BACILLUS CALMETTE-GUERIN | 100023013 |
| 20065293 | 20088940 | 1.74 | 92.1 | Palliative (P) | 2019-12-27 | 2019-12-27 | EEF or EOF | 01 | N | GEMCARBO | 100738854 |
| 20065736 | 20088941 | 1.7 | 81.9 | Palliative (P) | 2018-03-24 | 2018-03-24 | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 01 | N | MITOMYCIN | 100345045 |
| 20065739 | 20088942 | 1.7 | 50 | 03 | null | 2018-09-11 | Lenalidomide 25mg (Cycle 1 to 25) | null | N | FLUOROURACIL + STREPTOZOCIN | 100973252 |
| 20065775 | 20088943 | 1.79 | 71.6 | Palliative (P) | 2012-03-13 | 2018-10-02 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 101764724 |
| 20066993 | 20088944 | 1.6 | 0 | Palliative (P) | 2019-04-20 | 2019-04-20 | Carboplatin+Fluorouracil 4 or 5 day | 01 | N | GEMCARBO | 100921686 |
| 20067150 | 20088945 | 1.78 | 100 | 03 | 2017-12-05 | 2017-12-31 | MITOMYCIN | 01 | N | IRINOTECAN | 100313242 |
| 20068958 | 20088946 | 1.82 | 112 | Palliative (P) | 2018-02-22 | 2018-02-25 | Carboplatin + Docetaxel | 02 | N | IBRUTINIB | 101387348 |
| 20073243 | 20088949 | 1.73 | 81.8 | 03 | 2018-12-23 | 2018-12-24 | ESPAC-4 TRIAL | 02 | N | GEMCITABINE + PACLITAXEL | 100198859 |
| 20084150 | 20088950 | 1.78 | 62 | Palliative (P) | 2017-08-06 | 2017-09-08 | FOXTROT TRIAL | 01 | N | PLATO TRIAL | 100861511 |
| 20086771 | 20088951 | 1.87 | 62.5 | 03 | 2016-12-29 | 2017-01-11 | BUSULFAN | 01 | N | BORTEZOMIB | 101664916 |
| 20092444 | 20088952 | 1.69 | 59 | Palliative (P) | 2017-02-11 | 2017-02-22 | SCOPE 2 TRIAL | 02 | null | ACELARATE TRIAL | 100058981 |
| 20094036 | 20088953 | 1.71 | 75.8 | Adjuvant (A) | 2019-05-25 | 2019-06-04 | ECarboX | 02 | N | GEMCITABINE + OXALIPLATIN | 101473769 |
| 20101114 | 20088955 | 1.63 | null | Adjuvant (A) | 2019-10-05 | 2019-10-26 | Docetaxel | N | N | ACELARATE TRIAL | 101515352 |
| 20101840 | 20088956 | 1.57 | 115.9 | Palliative (P) | 2017-11-04 | 2017-11-30 | Cladribine (subcut) 5 days | 02 | N | MITOMYCIN | 100678107 |
| 20104479 | 20088957 | 0.6 | 70.2 | null | 2020-06-30 | 2020-07-06 | COSMIC TRIAL | 99 | N | EVEROLIMUS | 101366661 |
| 20104734 | 20088959 | 1.68 | 77 | Palliative (P) | 2020-01-12 | 2020-01-13 | CVP R | 01 | N | DOXORUBICIN + IFOSFAMIDE | 101866715 |
| 20104742 | 20088960 | 1.56 | null | Palliative (P) | 2020-12-11 | 2020-12-12 | Pertuzumab (Loading) | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101354924 |
| 20105583 | 20088961 | 1.78 | 76 | Palliative (P) | 2019-06-28 | 2019-07-12 | Irinotecan 14day | 01 | N | CAP + RT | 100331962 |
| 20106220 | 20088963 | 1.53 | null | 03 | 2019-09-09 | 2019-09-22 | CISPLATIN + TEYSUNO | 02 | N | CAP + RT | 100536685 |
| 20106338 | 20088964 | 1.77 | 86.4 | 03 | 2019-10-23 | 2019-10-23 | BCG Intravesical | 02 | Y | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 101280589 |
| 20106539 | 20088965 | 1.71 | 120.2 | Palliative (P) | 2018-11-30 | 2018-11-30 | Irinotecan 14day | 02 | N | AFATINIB | 100578527 |
| 20107276 | 20088966 | 1.61 | 63.1 | 03 | 2019-07-15 | 2019-07-28 | OXALIPLATIN + MDG + PANITUMUMAB | N | N | OXALIPLATIN + MDG + PANITUMUMAB | 100470913 |
| 20112612 | 20088969 | 1.71 | 70.2 | 03 | 2017-11-16 | 2017-11-16 | Carbo F | 02 | N | CARBOPLATIN + RT | 101479073 |